Cipla USA Launches Pomalidomide Capsules, Generic Version of Pomalyst®, in All Strengths
Cipla Limited and its wholly owned subsidiary, Cipla USA Inc., announced the commercial launch of Pomalidomide Capsules in the United States. The generic equivalent of Bristol Myers Squibb's Pomalyst® is...
Sun Pharma Among Nine Drugmakers Joining Trump Administration’s Most-Favoured-Nation Pricing Pact
The Trump administration has widened its most-favored-nation (MFN) drug pricing programme by signing nine fresh manufacturers into the initiative, taking the total roster of...
Pradhan Mantri Bhartiya Janaushadhi Pariyojana Records ₹2,252.19 Crore in Sales for FY 2025–26, Saving Citizens ₹9,000 Crore
The Department of Pharmaceuticals announced that the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) achieved total sales of ₹2,252.19 crore in the financial year 2025–26. The widespread availability of quality...
Department of Pharmaceuticals Integrates ‘Pharma Sahi Daam’ and ‘Pharma Jan Samadhan’ into a Single Unified Platform
The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, has officially integrated two essential citizen services, the Pharma Sahi Daam price-finding tool and the Pharma Jan Samadhan grievance redressal system into a single,...
Cipla Partners with SBP Group for Next-Gen HER2 Cancer Therapy
Cipla Limited and Sino Biopharmaceutical Limited (SBP Group) announced that SBP Group's subsidiary, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ), has entered into an exclusive license...
Eli Lilly to Acquire Merida Biosciences in $2.875B Deal to Advance Precision Immunology
Eli Lilly and Company has entered into a definitive agreement to acquire Merida Biosciences, Inc., a privately held biotechnology company developing precision antibody-based therapies...
